Pfizer, Haleon
Drug giant Pfizer sells $3.3 billion stake in Sensodyne-maker Haleon
Pfizer sold a stake in British consumer healthcare group Haleon worth about $3.26 billion on Monday, cutting its shareholding in the maker of Sensodyne toothpaste and Panadol and Advil painkillers to 15% from 22.
Haleon’s Rating Reconfirmed After Changes in Pfizer's Stake
Haleon PLC, leading to a significant share repurchase.,UBS has reaffirmed its positive rating on Haleon following this development.,Haleon plans to cancel half of the repurchased shares as part of its
Pfizer to Pare Back Haleon Stake With 540 Million Share Offering
Pfizer Inc. plans to sell 540 million worth of shares in Haleon Plc, as it pares back its holding in the UK consumer health giant.
Pfizer to offload about 5.9% stake in UK's Haleon, says bookrunner
Pfizer intends to offload about 540 million shares in the British consumer healthcare company Haleon, a bookrunner said on Monday. The proposed sale will reduce the top shareholder's interest in Sensodyne-maker Haleon to 16.
Pfizer raises US$3.2 billion by selling part of Haleon stake
Pfizer has raised about US$3.2 billion from the sale of Haleon shares, as it further reduces its stake in the UK consumer health company. Read more at The Business Times.
Pfizer to sell about $3.25 billion stake in Sensodyne-maker Haleon, bookrunner says
Haleon separately said on Monday it had agreed to make an off-market purchase of about 230 million pounds ($308.18 million) worth of ordinary shares from Pfizer. In March, the U.S. pharma major had sold about $3.
Pfizer sells $3.3 billion stake in Sensodyne-maker Haleon
Pfizer has sold a stake in British consumer healthcare group Haleon worth about $3.26 billion, cutting its shareholding in the maker of Sensodyne toothpaste and Panadol and Advil painkillers to 15% from 22.
Pfizer Intends to Sell Around 540 Million Ordinary Shares in Haleon -- Update
Pfizer will receive all net proceeds from the offering, it said. In a separate statement, Haleon said it agreed to make an off-market purchase of approximately 230 million pounds ($307.7 million) worth of its ordinary shares from Pfizer.
Haleon Announces Leadership Transition in Canada: Rupa Bahri to Depart, Christine Jakovcic Appointed as New General Manager
Haleon, a global leader in consumer health, today announced the appointment of Christine Jakovcic as General Manager, Haleon ...
FiercePharma1h
Pfizer gins up £2.4B after unloading hundreds of millions of Haleon shares
Following a similar move in March, Pfizer is offloading another tranche of Haleon shares. | Pfizer has sold 640 million ...
Pfizer to Receive 2.66 Billion Pounds From Haleon in Share Deal
Pfizer will receive around £2.7 billion in aggregate from Haleon from an offering and a share buyback.
Pfizer to sell about $3.25 bln stake in Sensodyne-maker Haleon, bookrunner says
Pfizer's stake sale in British consumer healthcare company Haleon has been upsized by 100 million shares to 640 million ...
Pfizer's Total Interest In Haleon To Reduce From Approx. 22.6% To Approx. 15.0%
Pfizer said, further to the Launch Announcement on 30 September 2024, it has sold 640 million ordinary shares in Haleon plc, at a ...
Dr Reddy's completes acquisition of Haleon's global NRT portfolio
DRL's Swiss subsidiary completed the acquisition through the purchase of shares of Northstar Switzerland SARL, a Haleon group ...